F. Catus
- Neurology top 5%
- Myasthenia Gravis and Thymoma 2
-
- Pituitary Gland Disorders and Treatments 10
- Growth Hormone and Insulin-like Growth Factors 6
- Epidemiology top 10%
- Neuroendocrine Tumor Research Advances 6
- Rehabilitation top 5%
-
- Pancreatic and Hepatic Oncology Research 1
-
- Adrenal and Paraganglionic Tumors 2
-
- Sympathectomy and Hyperhidrosis Treatments 1
-
- Gastroesophageal reflux and treatments 1
- Co-authors
- Gilles BommelaerDermot O’TooleMichel DucreuxPhilippe RuszniewskiJean-Louis WémeauFabienne ThomasIsabelle MorangePhilippe Chanson
In The Last Decade
F. Catus
12 papers receiving 709 citations
Peers
Comparison fields: 5 of 57
- Neurology 325
- Endocrinology, Diabetes and Metabolism 353
- Epidemiology 420
- Rehabilitation 78
- Oncology 182
Countries citing papers authored by F. Catus
This map shows the geographic impact of F. Catus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Catus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Catus more than expected).
Fields of papers citing papers by F. Catus
This network shows the impact of papers produced by F. Catus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Catus. The network helps show where F. Catus may publish in the future.
Co-authorship network
The 25 scholars most cited alongside F. Catus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 147 | |
| 2 | 2005 | 46 | |
| 3 | 2000 | 201 | |
| 4 | 2000 | 59 | |
| 5 | 1997 | 11 | |
| 6 | 1997 | 23 | |
| 7 | 1995 | 37 | |
| 8 | 1994 | 57 | |
| 9 | 1994 | 50 | |
| 10 | [Treatment of acromegaly with a new slow release somatostatin analog, lanreotide]. | 1994 | 3 |
| 11 | 1994 | 91 | |
| 12 | [Treatment of acromegaly with sustained-release lanreotide. A new somatostatin analog]. | 1993 | 11 |
About F. Catus
F. Catus is a scholar working on Endocrinology, Diabetes and Metabolism, Neurology, Gastroenterology, Epidemiology and Rehabilitation, having authored 12 papers that have together received 736 indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (10 papers), Neuroendocrine Tumor Research Advances (6 papers), Growth Hormone and Insulin-like Growth Factors (6 papers), Myasthenia Gravis and Thymoma (2 papers), Adrenal and Paraganglionic Tumors (2 papers), Pancreatic and Hepatic Oncology Research (1 paper), Sympathectomy and Hyperhidrosis Treatments (1 paper) and Gastroesophageal reflux and treatments (1 paper). The work is most often cited by research in Neurology (325 citations), Endocrinology, Diabetes and Metabolism (353 citations), Epidemiology (420 citations), Rehabilitation (78 citations) and Oncology (182 citations). F. Catus has collaborated with scholars based in France, Czechia and Poland. Frequent co-authors include Gilles Bommelaer, Dermot O’Toole, Michel Ducreux, Philippe Ruszniewski, Jean-Louis Wémeau, Fabienne Thomas, Isabelle Morange, Philippe Chanson, B. Lucas and Didier Dewailly. Their work appears in journals such as European Journal of Endocrinology, The Journal of Clinical Endocrinology & Metabolism, Clinical Endocrinology, British Journal of Clinical Pharmacology and The Lancet Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.